Pathogenesis and therapy of anemia in oncohemathology patients with recombinant erythropoietin agents (review)

Pathogenesis and therapy of anemia in oncohemathology patients with recombinant erythropoietin agents (review)

Show other versions (1)

The article presents a literature review on the mechanisms of anemia in patients with hematologic malignancies and a classification of chronic anemia and methods of its correction. It describes in detail the mechanism of action, indications and side effects of rembinant erythropoietin (rEPO). It giv...

Full description

Bibliographic Details
Main Author:	N. A. Romanenko
Format:	Article
Language:	Russian
Published:	ABV-press 2014-07-01
Series:	Onkogematologiâ
Subjects:	anemia non hodgkin’s lymphomas lymphoproliferative disorders multiple myeloma chronic myeloid leukemia myelodisplastic syndrome hemoglobin erythropoietin darbepoetin chemotherapy red blood cell transfusion
Online Access:	https://oncohematology.abvpress.ru/ongm/article/view/50

Similar Items

Pathogenesis and therapy of anemia in oncohemathology patients with recombinant erythropoietin agents (review)
by: N. A. Romanenko
Published: (2014-07-01)

Patogenetic correction of anemia with erythropoiesis-stimulating agents in lymphoproliferative disorders (literature review)
by: N. A. Romanenko, et al.
Published: (2014-07-01)

Patogenetic correction of anemia with erythropoiesis-stimulating agents in lymphoproliferative disorders (literature review)
by: N. A. Romanenko, et al.
Published: (2014-07-01)

Pathogenesis and correction of anemic syndrome in lymphoproliferative disorders patients
by: N A Romanenko
Published: (2013-03-01)

Correction of anemia in multiple myeloma patients by erythropoiesis-stimulating agents
by: N. A. Romanenko, et al.
Published: (2014-07-01)

Correction of anemia in multiple myeloma patients by erythropoiesis-stimulating agents
by: N. A. Romanenko, et al.
Published: (2014-07-01)

Randomized Study of Darbepoetin Alfa and Recombinant Human Erythropoietin for Treatment of Renal Anemia in Chronic Renal Failure Patients Receiving Peritoneal Dialysis
by: Wen-Yi Li, et al.
Published: (2008-11-01)

Hemoglobin levels and quality of life in patients with symptomatic chemotherapy-induced anemia: the eAQUA study
by: Mouysset JL, et al.
Published: (2016-01-01)

Erythropoietin use and abuse
by: M Joseph John, et al.
Published: (2012-01-01)

The Effects of Erythropoietin in the Management of Anemia of Chronic Renal Failure in Patients on Hemodialysis
by: M Rahimian, et al.
Published: (2005-04-01)

Darbepoetin Use for the Treatment of Anemia in Hemodialysis Patients in Saudi Arabia
by: Shaheen Faissal, et al.
Published: (2006-01-01)

The role of erythropoietins in cancer therapy
by: O. E. Kondratieva, et al.
Published: (2018-07-01)

The Role Of Erythropoietin In The Treatment Of Anemia In Patients With Malignant Lymphoma
by: Kurtus Aranka, et al.
Published: (2013-06-01)

O efeito da eritropoetina humana recombinante no tratamento da anemia da prematuridade The effect of recombinant human erythropoietin on the treatment of anemia of prematurity
by: Vera Lúcia L. Rocha, et al.
Published: (2001-04-01)

Prognostic value of a number of blood laboratory parameters in the use of erythropoiesis-stimulating agents in anemic patients with lymphoproliferative diseases
by: N A Romanenko, et al.
Published: (2013-08-01)

RATIONAL SUPPORTIVE THERAPY FOR CHEMOTHERAPY INDUCED ANEMIA: A PHARMACO-ECONOMIC ANALYSIS OF ERYTHROPOIETIN THERAPY IN CANCER PATIENTS IN RUSSIAN FEDERATION
by: V. B. Larionova, et al.
Published: (2018-07-01)

Comparative efficacy and safety of biosimilar darbepoetin alfa in adults with anemia of chronic kidney disease
by: Prasad Apsangikar, et al.
Published: (2018-01-01)

Effects of Single Dose of Erythropoietin on Blood Transfusion Requirement in Patients Undergoing Coronary Artery Bypass Graft Surgery
by: SH Ziabakhsh-Tabary, et al.
Published: (2013-03-01)

Efficacy, tolerability and safety of darbepoetin alfa injection for the treatment of anemia associated with chronic kidney disease (CKD) undergoing dialysis: a randomized, phase-III trial
by: Shubhadeep D. Sinha, et al.
Published: (2019-03-01)

SEARCH OF NEW PHARMACEUTICALS ON THE BASIS OF DARBEPOETIN IN THE TREATMENT OF ISCHEMIC STROKE (REVIEW OF LITERATURE)
by: Konstantin Reznikov, et al.
Published: (2017-03-01)

HIGH SERUM ERYTHROPOIETIN AND FERRITIN LEVELS ASSOCIATED WITH ANEMIA RESPONSE IN MALIGNANT LYMPHOMA
by: Sofia Omari, et al.
Published: (2011-05-01)

HIGH SERUM ERYTHROPOIETIN AND FERRITIN LEVELS ASSOCIATED WITH ANEMIA RESPONSE IN MALIGNANT LYMPHOMA
by: Alhossain A. Khalafallah, et al.
Published: (2011-01-01)

Use of Recombinant Human Erythropoietin in Renal Anemia in Children
by: Habibur Rahman, et al.
Published: (2009-11-01)

"EFFECT OF HIGH VERSUS LOW DOSES OF HUMAN RECOMBINANT ERYTHROPOIETIN ON THE ANEMIA OF PREMATURITY"
by: A. Mohammadzadeh, et al.
Published: (2005-05-01)

"EFFECT OF HIGH VERSUS LOW DOSES OF HUMAN RECOMBINANT ERYTHROPOIETIN ON THE ANEMIA OF PREMATURITY"
by: A. Mohammadzadeh, et al.
Published: (2005-04-01)

LONG-ACTING ERYTHROPOETIN EFFICACY IN THE TREATMENT OF NEPHROGENIC ANEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE AT A PREDIALYSIS STAGE
by: Yu S Milovanov, et al.
Published: (2012-06-01)

Pathogenetic and substitution correction of anemia in patients with malignant neoplasms
by: N. A. Romanenko, et al.
Published: (2020-10-01)

Chronic lymphoproliferative diseases: survival in cohort study of 310 patients (single-center study results and literature data)
by: V. P. Pop, et al.
Published: (2015-01-01)

Chronic lymphoproliferative diseases: survival in cohort study of 310 patients (single-center study results and literature data)
by: V. P. Pop, et al.
Published: (2015-01-01)

EARLY ADMINISTRATION OF ERYTHROPOIETIN IN EXTREMELY VERY LOW BIRTH WEIGHT PRETERMS
by: Mihaela Demetrian, et al.
Published: (2019-09-01)

Pharmacoeconomic analysis of long term use of darbepoetin-α in treating chronic nephropathy-induced anemia in dialysed patients
by: Nicola Giotta, et al.
Published: (2007-06-01)

APPLICATION OF ERYTHROPOIETIN THETA IN THERAPY OF ANEMIA IN ONCOLOGIC PATIENTS
by: O. A. GLADKOV, et al.
Published: (2016-12-01)

New alternatives for erythropoietin therapy in chronic renal failure
by: Stoian Irina, et al.
Published: (2007-12-01)

The assessment of native erythropoietin and antibodies to recombinant erythropoietin in haemodialysis patients
by: Benjamin, Sherilene Cheryl
Published: (2008)

The assessment of native erythropoietin and antibodies to recombinant erythropoietin in haemodialysis patients
by: Benjamin, Sherilene Cheryl
Published: (2008)

Erythropoietin Protects the Kidney by Regulating the Effect of TNF-α in L-NAME-Induced Hypertensive Rats
by: Mete Ozkurt, et al.
Published: (2018-05-01)

Prevalence and intervention of preoperative anemia in Chinese adults: A retrospective cross-sectional study based on national preoperative anemia database
by: Jie Lin, et al.
Published: (2021-06-01)

A meta-analysis and systematic review evaluating the use of erythropoietin in total hip and knee arthroplasty
by: Li Y, et al.
Published: (2018-07-01)

Anemias in Oncology: Potential of Maintenance Therapy
by: AV Snegovoi, et al.
Published: (2016-07-01)

Aspects of the pathogenesis of anemia in cancer patients
by: N A Romanenko, et al.
Published: (2019-12-01)